Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study
1 other identifier
observational
400
1 country
3
Brief Summary
This multicenter study aims to evaluate clinical outcomes and optimize management strategies in patients with early colorectal cancer who undergo non-curative endoscopic resection. Patients with non-curative resection following endoscopic treatment will be enrolled across multiple centers and managed according to real-world clinical decisions, including additional surgery or surveillance. Baseline demographic, endoscopic, and pathological characteristics will be systematically collected. The primary objective is to compare recurrence and survival outcomes between different management strategies. Secondary objectives include identifying prognostic factors associated with recurrence and developing a risk stratification model to guide individualized treatment decisions. All participants will undergo standardized follow-up according to clinical guidelines. This study is expected to provide real-world evidence to refine risk assessment, reduce unnecessary surgery, and improve personalized management for patients with early colorectal cancer after non-curative endoscopic resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 21, 2026
April 1, 2026
3 years
April 14, 2026
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence-Free Survival
Up to 2 years
Secondary Outcomes (1)
Association Between High-Risk Pathological Factors and Recurrence
Up to 2 years
Study Arms (2)
Additional Surgery
Patients who underwent additional surgical resection following non-curative endoscopic resection based on pathological risk factors and clinical decision-making.
Surveillance
Patients managed with surveillance after non-curative endoscopic resection, including regular endoscopic and imaging follow-up without additional surgical intervention.
Interventions
Additional surgical resection performed after non-curative endoscopic resection based on pathological risk factors and clinical indications.
Active surveillance with regular endoscopic and imaging follow-up without additional surgical intervention.
Eligibility Criteria
This multicenter cohort study includes adult patients with early colorectal cancer who underwent non-curative endoscopic resection. Participants are stratified into additional surgery and surveillance groups based on post-resection management strategies. Comprehensive clinicopathological characteristics and follow-up data are collected to evaluate recurrence patterns, survival outcomes, and to develop and validate a risk prediction model.
You may qualify if:
- Age ≥18 years;
- Patients with early colorectal cancer confirmed by histopathology;
- Patients who underwent endoscopic resection (including EMR, ESD, or equivalent techniques);
- Pathological diagnosis indicating non-curative resection, defined by the presence of at least one of the following: positive resection margin, submucosal invasion depth \>1000 μm, poor differentiation, lymphovascular invasion, perineural invasion, or high-grade tumor budding;
- Availability of complete clinicopathological and follow-up data;
- Patients managed with either additional surgery or surveillance after endoscopic resection.
You may not qualify if:
- Patients with synchronous advanced colorectal cancer or distant metastasis at baseline;
- History of other active malignancies;
- Patients with inflammatory bowel disease, familial adenomatous polyposis, or other hereditary colorectal cancer syndromes;
- Patients who received neoadjuvant therapy before endoscopic resection;
- Incomplete pathological data or missing key variables;
- Loss to follow-up or follow-up duration less than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Shenzhen Longgang District People's Hospital
Shenzhen, Guangdong, China
The Second Affiliated Hospital of Guangzhou Medical University
Haizhu, Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 21, 2026
Study Start
September 3, 2025
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share